Company Filing History:
Years Active: 2011-2012
Title: Jani Vainio: Innovator in Anti-VAP-1 Antibodies
Introduction
Jani Vainio is a notable inventor based in Halikko, Finland. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents to his name, Vainio's work focuses on innovative methods for treating inflammatory conditions.
Latest Patents
Vainio's latest patents include groundbreaking methods of treating inflammatory conditions involving VAP-1-mediated adhesion with VAP-1-specific antibodies. These patents disclose novel fully human anti-VAP-1 antibodies and fragments thereof. They also encompass nucleic acids encoding these antibodies, as well as expression vectors and host cells that facilitate the recombinant expression of anti-VAP-1 antibodies. Additionally, pharmaceutical compositions comprising these antibodies and their therapeutic uses are detailed in his patents. Another significant patent involves fully human anti-VAP-1 monoclonal antibodies, further emphasizing his commitment to advancing medical treatments.
Career Highlights
Jani Vainio is associated with Biotie Therapies Corporation, where he continues to innovate in the field of therapeutic antibodies. His work has the potential to impact the treatment of various inflammatory conditions, showcasing his dedication to improving healthcare outcomes.
Collaborations
Vainio collaborates with esteemed colleagues, including David Smith and Petri Vainio. These partnerships enhance the research and development efforts within his field, fostering innovation and progress.
Conclusion
Jani Vainio's contributions to the development of anti-VAP-1 antibodies represent a significant advancement in biotechnology. His innovative patents and collaborations highlight his role as a key figure in the pursuit of effective treatments for inflammatory conditions.